InsiderClue
Insiders · Profile

Burke William P. Mr.

Director at Axogen · EVP, Chief Financial Officer at HAEMONETICS. Filing since 25 Oct 2017. CIK 0001682069

AXGN Axogen, Inc. Director · 14 trades HAE HAEMONETICS CORP EVP, Chief Financial Officer · 26 trades
Company
Date
Role
Action
Shares
Amount
Of holding
AXGN Axogen, Inc.
11 Nov 2025
Director
Sold on a plan
3,591
$86.25K
97.3%
AXGN Axogen, Inc.
10 Nov 2025
Director
Sold on a plan
19,227
$461.64K
99.5%
AXGN Axogen, Inc.
6 Nov 2025
Director
Sold on a plan
5,347
$128.37K
98.2%
AXGN Axogen, Inc.
5 Nov 2025
Director
Sold on a plan
11,431
$274.89K
99.1%
AXGN Axogen, Inc.
30 Oct 2025
Director
Sold on a plan
18,248
$419.70K
99.5%
AXGN Axogen, Inc.
29 Oct 2025
Director
Sold on a plan
40,235
$827.01K
99.8%
AXGN Axogen, Inc.
22 Oct 2025
Director
Sold on a plan
1,457
$26.25K
93.6%
AXGN Axogen, Inc.
6 Oct 2025
Director
Sold at will
736
$13.25K
32.1%
AXGN Axogen, Inc.
3 Oct 2025
Director
Sold on a plan
14,571
$265.28K
86.4%
AXGN Axogen, Inc.
3 Oct 2025
Director
Sold on a plan
7,600
$138.37K
100%
AXGN Axogen, Inc.
2 Oct 2025
Director
Sold on a plan
7,620
$137.20K
31.1%
AXGN Axogen, Inc.
2 Oct 2025
Director
Sold on a plan
2,400
$43.22K
24.0%
AXGN Axogen, Inc.
9 Jun 2025
Director
Sold at will
4,073
$43.21K
14.3%
AXGN Axogen, Inc.
23 Aug 2023
Director
Bought
10,000
$65.60K
opened
HAE HAEMONETICS CORP
23 Aug 2021
EVP, Chief Financial Officer
Sold, plan not stated
22,667
$1.37M
42.8%
HAE HAEMONETICS CORP
1 Jul 2021
EVP, Chief Financial Officer
Sold, plan not stated
4,293
$285.91K
12.4%
HAE HAEMONETICS CORP
14 Jun 2021
EVP, Chief Financial Officer
Sold, plan not stated
190
$11.38K
0.5%
HAE HAEMONETICS CORP
7 Jun 2021
EVP, Chief Financial Officer
Sold, plan not stated
411
$22.64K
1.2%
HAE HAEMONETICS CORP
19 May 2021
EVP, Chief Financial Officer
Sold, plan not stated
238
$13.14K
0.7%
HAE HAEMONETICS CORP
17 May 2021
EVP, Chief Financial Officer
Sold, plan not stated
219
$12.26K
1.9%
HAE HAEMONETICS CORP
26 Oct 2020
EVP, Chief Financial Officer
Sold, plan not stated
1,161
$123.07K
9.3%
HAE HAEMONETICS CORP
16 Jun 2020
EVP, Chief Financial Officer
Sold, plan not stated
12,614
$1.15M
50.2%
HAE HAEMONETICS CORP
15 Jun 2020
EVP, Chief Financial Officer
Sold, plan not stated
9,720
$852.54K
27.9%
HAE HAEMONETICS CORP
12 Jun 2020
EVP, Chief Financial Officer
Sold, plan not stated
197
$17.59K
0.6%
HAE HAEMONETICS CORP
8 Jun 2020
EVP, Chief Financial Officer
Sold, plan not stated
639
$62.00K
4.8%
HAE HAEMONETICS CORP
15 May 2020
EVP, Chief Financial Officer
Sold, plan not stated
221
$22.20K
2.1%
HAE HAEMONETICS CORP
29 Oct 2019
EVP, Chief Financial Officer
Sold, plan not stated
1,448
$177.66K
12.2%
HAE HAEMONETICS CORP
28 Oct 2019
EVP, Chief Financial Officer
Sold, plan not stated
1,155
$138.98K
8.9%
HAE HAEMONETICS CORP
25 Oct 2019
EVP, Chief Financial Officer
Sold, plan not stated
11,231
$1.35M
46.3%
HAE HAEMONETICS CORP
9 Oct 2019
EVP, Chief Financial Officer
Sold, plan not stated
22,704
$2.82M
63.6%
HAE HAEMONETICS CORP
8 Oct 2019
EVP, Chief Financial Officer
Sold, plan not stated
18,950
$2.32M
34.7%
HAE HAEMONETICS CORP
1 Oct 2019
EVP, Chief Financial Officer
Sold, plan not stated
7,164
$901.20K
35.5%
HAE HAEMONETICS CORP
12 Jun 2019
EVP, Chief Financial Officer
Sold, plan not stated
190
$20.78K
1.3%
HAE HAEMONETICS CORP
7 Jun 2019
EVP, Chief Financial Officer
Sold, plan not stated
411
$42.49K
2.7%
HAE HAEMONETICS CORP
8 Nov 2018
EVP, Chief Financial Officer
Sold, plan not stated
13,056
$1.49M
52.1%
HAE HAEMONETICS CORP
26 Oct 2018
EVP, Chief Financial Officer
Sold, plan not stated
779
$79.22K
5.3%
HAE HAEMONETICS CORP
25 Jun 2018
EVP, Chief Financial Officer
Sold, plan not stated
6,687
$616.34K
31.4%
HAE HAEMONETICS CORP
7 Jun 2018
EVP, Chief Financial Officer
Sold, plan not stated
425
$39.41K
3.2%
HAE HAEMONETICS CORP
14 Nov 2017
EVP, Chief Financial Officer
Sold, plan not stated
13,193
$712.90K
48.5%
HAE HAEMONETICS CORP
25 Oct 2017
EVP, Chief Financial Officer
Sold, plan not stated
841
$39.33K
5.9%
40 decisions on file.